Back Bay Life Science Report

Jonathan P. Gertler, MD and Peter Bak, PhD

Subscribe in Parasocial

Free on the App Store for iPhone, iPad and Mac. No subscription needed. Once it is installed, tap this link again and the show is yours. Already have it? Open in Parasocial.

About

Back Bay Life Science Advisors brings you expert insights from our strategic advisors and investment bankers on biopharma, medtech, and medical device development, trends, and growth areas. On this podcast, you’ll hear from our experts in life science development, commercialization, and investment banking, scientific investigators, biotech and medtech executives, physicians, and strategists who excel at guiding global life sciences companies and their investors through complex decisions. Join us for insights generated from in-depth scientific, strategic, and financial analysis at the intersection of science and business.

Also on

Recent episodes

  • Evolving Oncology: The Expanding Landscape of Targeted Therapies and InvestmentApr 15, 2026 · 30 min
  • ADC Revolution in Ovarian Cancer: Current Developments and Future OutlookMar 5, 2026 · 30 min
  • 2025 Drug Approval ReviewFeb 9, 2026 · 29 min
  • A Capital Markets Outlook for 2025: 2024, A Year in ReviewFeb 7, 2025 · 16 min
  • Navigating Healthcare Capital Markets in 2025: A Year of Cautious OptimismFeb 6, 2025 · 16 min
  • The Optimism of Bispecific AntibodiesNov 8, 2024 · 27 min
  • Dynamics in Healthcare Focused MarketsSep 30, 2024 · 21 min
  • From NASH to MASH: Current Market Dynamics in HepatologySep 16, 2024 · 28 min
  • Key Considerations for a US Healthcare IPOMay 22, 2024 · 35 min
  • Drug Development in ObesityApr 30, 2024 · 27 min

Website · RSS feed